Ziprasidone in the Treatment of Borderline Personality Disorder

This study has been completed.

Sponsor:

Collaborators:

Ministry of Health, Spain

REM-TAP Network

Pfizer

Information provided by:

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

ClinicalTrials.gov Identifier:

NCT00635921

First received: March 11, 2008

Last updated: NA

Last verified: March 2008

History: No changes posted

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Study Completion Date:	April 2006
Primary Completion Date:	April 2006 (Final data collection date for primary outcome measure)

No publications provided by Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Pascual JC, Soler J, Puigdemont D, Pérez-Egea R, Tiana T, Alvarez E, Pérez V. Ziprasidone in the treatment of borderline personality disorder: a double-blind, placebo-controlled, randomized study. J Clin Psychiatry. 2008 Apr;69(4):603-8.

To Top